ADB116
/ Jiangsu Aidea Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 06, 2026
Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection
(clinicaltrials.gov)
- P1 | N=34 | Recruiting | Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. | N=26 ➔ 34 | Trial completion date: Aug 2026 ➔ Mar 2027 | Trial primary completion date: Aug 2026 ➔ Dec 2026
Enrollment change • Trial completion date • Trial primary completion date
July 29, 2026
Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection
(clinicaltrials.gov)
- P1 | N=26 | Recruiting | Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1